Teza Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Sell |
6,660
-45
| -0.7% | -$1.42K | 0.16% | 267 |
|
|
2025
Q1 | $220K | Buy |
6,705
+83
| +1% | +$2.72K | 0.1% | 336 |
|
|
2024
Q4 | $239K | Sell |
6,622
-2,276
| -26% | -$82.3K | 0.04% | 405 |
|
|
2024
Q3 | $277K | Buy |
+8,898
| New | +$277K | 0.03% | 495 |
|
|
2021
Q3 | – | Sell |
-11,299
| Closed | -$348K | – | 575 |
|
|
2021
Q2 | $348K | Buy |
+11,299
| New | +$348K | 0.06% | 404 |
|
|
2019
Q4 | – | Sell |
-30,372
| Closed | -$835K | – | 715 |
|
|
2019
Q3 | $835K | Buy |
+30,372
| New | +$835K | 0.21% | 159 |
|